Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
NBIX

Neurocrine

$109.14

-3.12 (-2.78%)

16:02
10/09/18
10/09
16:02
10/09/18
16:02
Hot Stocks
Neurocrine and Jnana Therapeutics enter into research collaboration »

Neurocrine Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$112.26

-3.34 (-2.89%)

04:55
10/09/18
10/09
04:55
10/09/18
04:55
Conference/Events
International Parkinson & Movement Disorder Society to hold a conference »

MDS Congress 2018 will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$115.60

1.2 (1.05%)

07:47
10/08/18
10/08
07:47
10/08/18
07:47
Conference/Events
International Parkinson & Movement Disorder Society to hold a conference »

MDS Congress 2018 will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$114.40

-4.65 (-3.91%)

06:12
10/05/18
10/05
06:12
10/05/18
06:12
Recommendations
Neurocrine analyst commentary at Piper Jaffray »

Piper positive on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Oct

NBIX

Neurocrine

$121.55

1.7 (1.42%)

10:45
09/24/18
09/24
10:45
09/24/18
10:45
Conference/Events
Neurocrine has a conference call hosted by JPMorgan »

JPMorgan Analyst Rama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

NBIX

Neurocrine

$119.85

-0.31 (-0.26%)

09:15
09/24/18
09/24
09:15
09/24/18
09:15
Conference/Events
Neurocrine has a conference call hosted by JPMorgan »

JPMorgan Analyst Rama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

NBIX

Neurocrine

$117.25

-3.07 (-2.55%)

07:19
09/20/18
09/20
07:19
09/20/18
07:19
Recommendations
Neurocrine analyst commentary at Stifel »

Neurocrine odds of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$120.32

3.03 (2.58%)

07:25
09/19/18
09/19
07:25
09/19/18
07:25
Recommendations
Neurocrine analyst commentary at Cantor Fitzgerald »

Cantor more confident in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$119.57

2.28 (1.94%)

12:25
09/18/18
09/18
12:25
09/18/18
12:25
Conference/Events
Cantor Fitzgerald biotech analyst to hold an analyst/industry conference call »

Analyst Research Team,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 18

    Sep

NBIX

Neurocrine

$117.29

-1.03 (-0.87%)

04:55
09/18/18
09/18
04:55
09/18/18
04:55
Conference/Events
Cantor Fitzgerald biotech analyst to hold an analyst/industry conference call »

Analyst Research Team,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 18

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.